Table 1.

Patient characteristics

	Patient 1	Patient 2	Patient 3
Age (years)	24	39	49
Sex	F	F	F
Duration of symptoms (years) (continuous)	4	4	5
Dermographism	Negative	Negative	Negative
Total serum IgE (IU/mL)	492.89	300.57	463.72
Anti-thyroglobulin antibody (IU/mL)	55	(+) (343)	2
Anti-microsomal antibody (IU/mL)	(+) (70)	(+) (806)	(+) (55)
Anti-Helicobacter pylori antibody (U/mL)	(+) (135)	(+) (280)	(+) (310)
Autologous skin test	(+) to serum	(+) to serum	(+) to serum

(+) positive, titer shown in parentheses. Autoantibody titers were before the start of the therapy with omalizumab